References
- 1. Ennaceur A, Chazot LP. Preclinical animal anxiety research-flaws and prejudices. Pharma Res Per. 2016;4(2):e00223.
- 2. Campos CA, Fogaca VM, Aguiar CD, Guimaraes SF. Animal models of anxiety disorders and stress. Revista Brasileira de Psiquiatria. 2013;35:101-11.
- 3. Sasaguri H, Nilson P, Hashimoto S, Nagata K, Saito T, De Strooper B, Hardy J, Vassar R, Winblad B, Saido CT. APP mouse models for Alzheimer's disease preclinical studies. The EMBO Journal. 2017;36:2473-87.
- 4. Shabani M, Nazeri M, Parsania S, Razavinasab M, Zangiabadi N, Esmaeilpour K, Abareghi F. Walnut consumption protects rats against cisplatin-induced neurotoxicity. NeuroToxicology. 2012;33:1314-21.
- 5. Onos DK, Sukoff Rizzo JS, Howell RG, Sasner M. Toward more predictive genetic mouse models of Alzheimer's disease. Brain Res Bull. 2016;122:1-11.
- 6. Glover EM, Clinton MS. Of rodents and humans: a comparative rewiev of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci. 2016;51:50-72.
- 7. Weinstock M. Prenatal stressors in rodents: effects on behavior. Neurobiology of stress. 2017;6:3-13.
- 8. Toyoda A. Social defeat models in animal science: What we have learned from rodent models. Animal Science Journal. 2017;88:944-52.
- 9. Stephanichev YM, Tishkina OA, Novikova RM, Levshina PI, Freiman VS, Onufriev NM, Levchenko AO, Lazareva AN, Gulyaeva VN. Anhedonia but not passive floating is an indicator of depressive-like behavior in two chronic stress paradigms. Acta Neurobiol. Exp. 2016;76:324-33.
- 10. Joksimovic J, Selakovic D, Matovic M, Zaletel I, Puskas N, Rosic G. The role of neuropeptide-Y in nandrolone decanoate-induced atenuation of antidepressant effect of exercise. PloS ONE. 2017;12(6):e0178922.
- 11. Kushwah N, Jain V, Deep S, Prasad D, Bala Singh S, Khan N. Neuroprotective role of intermittent hypobaric hypoxia in unpredictable chronic mild stress induced depression in rats. PloS ONE. 2016; 11(2):e0149309.
- 12. Magnard R, Vachez Y, Carcenac C, Krack P, David O, Savasta M, Boulet S, Carnicella S. What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease ? Transl. Psychiatry. 2016;6:e753.
- 13. Tomoda T, Sumitomo A, Jaaro-Peled H, Sawa A. Utility and validity of DISC1 mouse models in biological psychiatry. Neuroscience. 2016;321:99-107.
- 14. Seillier A, Giuffrida A. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: possible involvement of the endocannabinoid system. Eur Neuropsychopharmacol. 2016;26(2):298-309.
- 15. Logan WR, McClung AC. Animal models of bipolar mania: the past, present and future. Neuroscience. 2016;321:163-88.
- 16. Teng LB, Nikolova DV, Riddick VN, Agster LK, Crowley JJ, Baker LK, Koller HB, Pedersen AC, Jarstfer BM, Moy SS. Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology. 2016;105:61-71.
- 17. Teng LB, Nonneman JR, Agster LK, Nikolova DV, Davis TT, Riddick VN, Baker KL, Pedersen AC, Jarstfer BM, Moy SS. Prosocial effects of oxyocin in two mouse models of autism spectrum disorders. Neuropharmacology. 2013;72:187-96.
- 18. Selakovic D, Joksimovic J. Behavioral effects of shortterm total food restriction in rats. Ser J Exp Cli Res. 2014;15(3):129-37.
- 19. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005-11.
- 20. Ohlsson AL, Johansson BB. Environment influences functional outcome of cerebral infarction in rats. Stroke. 1995;26(4):644-9.
- 21. Rosic G, Joksimovic J, Selakovic D, Milovanovic D, Jakovljevic V. Anxiogenic effects of chronic exposure to nandrolone decanoate (ND) at supraphysiological dose in rats: a brief report. Neuro Endocrinol Lett. 2014;35(8):703-10.
- 22. Selakovic D, Joksimovic J, Zaletel I, Puskas N, Matovic M, Rosic G. The opposite effects of nandrolone decanoate and exercise on anxiety levels in rats may involve alterations in hippocampal parvalbumin-positive interneurons. PLoS One. 2017;12(12):e0189595.
- 23. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl). 2001;155(3):315-22.
- 24. Kalueff AV, Tuohimaa P. Experimental modeling of anxiety and depression. Acta Neurobiol Exp (Wars). 2004;64(4):439-48.
- 25. Graeff FG, Guimareas FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54(1):129-41.
- 26. Cryan JF, Leonard BE. 5-HT1A and beyond: the role of serotonin ant its receptors in depression and the antidepressant response. Hum. Psychopharmacol. 2000;15(2):113-35.
- 27. Mombereau C, Kaupmann K, Froesti W, Sansing G, Van der Putten H, Cryan JE. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology. 2004;29(6):1050-62.
- 28. Pellow S, Chpoin P, Fill SE, Briley M. Validation of open: closed arm antries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-67.
- 29. Pellow S, Fill SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav. 1986;24(3):525-9.
- 30. Selakovic D, Joksimovic J, Obradovic D, Milovanovic D, Djuric M, Rosic G. The adverse effects of exercise and supraphysiological dose of testosterone-enanthate (TE) on exploratory activity in elevated plus maze (EPM) test – indications for using total exploratory activity (TEA) as a new parameter for exploratory activity estimation in EPM. Neuroendocrinol Lett. 2016;37(5):383-8.
- 31. Cherwat R, Thierry B, Mico JA, Steru L, Simon P. Adaptation of the tail suspension test to the rat. J Pharmacol. 1986;17(3):348-50.
- 32. Joksimovic J, Selakovic D, Jakovljevic V, Mihailovic V, Katanic J, Boroja T, Rosic G. Alterations of the oxidative status in rat hippocampus and prodepressant effect of chronic testosterone enanthate administration. Mol Cell Biochem. 2017;433(1):41-50.
- 33. Mayorga AJ, Lucki I. Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berl). 2001;155(1):110-2.